General MedicationsINJECTIONGeneric
METARAMINOL BITARTRATE
METARAMINOL BITARTRATE
Standard Dose
EQ 20MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview METARAMINOL BITARTRATE is listed in Drugs@FDA under application 086418 (ANDA).
Marketing status: Discontinued Active ingredient METARAMINOL BITARTRATE Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/ML Sponsor GD SEARLE LLC Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview METARAMINOL BITARTRATE is listed in Drugs@FDA under application 086418 (ANDA). Marketing status: Discontinued Active ingredient METARAMINOL BITARTRATE Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/ML Sponsor GD SEARLE LLC Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.